RIP2, a Checkpoint in Myogenic Differentiation

REFERENCES

• Borycki, A. G., and C. P. Emerson. 1997. Muscle determination: another key player in myogenesis. Curr. Biol. 7: R620–623.
   PubMedGoogle Scholar
• Chinnaiyan, A. M., C. G. Tepper, M. F. Seldin, K. O'Rourke, F. C. Kischkel, S. Hellbardt, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271: 4961–4965.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475–1489.
   PubMed Web of Science ®Google Scholar
• Dorman, C. M., and S. E. Johnson. 2000. Activated Raf inhibits myogenesis through a mechanism independent of activator protein 1-mediated myoblast transformation. J. Biol. Chem. 275: 27481–27487.
   PubMedGoogle Scholar
• Duan, H., and V. M. Dixit. 1997. RAIDD is a new "death' adaptor molecule. Nature 385: 86–89.
   PubMed Web of Science ®Google Scholar
• Durkop, H., H. D. Foss, G. Demel, H. Klotzbach, C. Hahn, and H. Stein. 1999. Tumor necrosis factor receptor associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells. Blood 93: 617–623.
   PubMed Web of Science ®Google Scholar
• Endesfelder, S., A. Krahn, K. A. Kreuzer, U. Lass, C. A. Schmidt, C. Jahrmarkt, A. von Moers, and A. Speer. 2000. Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per se. J. Mol. Med. 78: 569–574.
   PubMedGoogle Scholar
• Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, Jr. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19: 5785–5799.
   PubMed Web of Science ®Google Scholar
• Guttridge, D. C., M. W. Mayo, L. V. Madrid, C.-Y. Wang, and A. S. Baldwin, Jr. 2000. NF-κB-induced loss of myoD messenger RNA: possible role in muscle decay and cachexia. Science 289: 2363–2366.
   PubMed Web of Science ®Google Scholar
• Hsu, H., J. Huang, H. B. Shu, V. Baichwal, and D. V. Goeddel. 1996. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4: 387–396.
   PubMed Web of Science ®Google Scholar
• Inohara, N., L. del Peso, T. Koseki, S. Chen, and G. Nunez. 1998. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273: 12296–12300.
   PubMedGoogle Scholar
• Jones, N. C., Y. V. Fedorov, R. S. Rosenthal, and B. B. Olwin. 2001. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J. Cell Physiol. 186: 104–115.
   PubMedGoogle Scholar
• Karin, M. 1999. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene 18: 6867–6874.
   PubMed Web of Science ®Google Scholar
• Kasof, G. M., J. C. Prosser, D. Liu, M. V. Lorenzi, and B. C. Gomes. 2000. The RIP-like kinase, RIP3, induces apoptosis and NF-κB nuclear translocation and localizes to mitochondria. FEBS Lett. 473: 285–291.
   PubMedGoogle Scholar
• Kelliher, M. A., S. Grimm, Y. Ishida, F. Kuo, B. Z. Stanger, and P. Leder. 1998. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8: 297–303.
   PubMed Web of Science ®Google Scholar
• McCarthy, J. V., J. Ni, and V. M. Dixit. 1998. RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J. Biol. Chem. 273: 16968–16975.
   PubMed Web of Science ®Google Scholar
• Miller, S. C., H. Ito, H. M. Blau, and F. M. Torti. 1988. Tumor necrosis factor inhibits human myogenesis in vitro. Mol. Cell. Biol. 8: 2295–2301.
   PubMed Web of Science ®Google Scholar
• Molkentin, J. D., and E. N. Olson. 1996. Defining the regulatory networks for muscle development. Curr. Opin. Genet. Dev. 6: 445–453.
   PubMed Web of Science ®Google Scholar
• Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587–3596.
   PubMed Web of Science ®Google Scholar
• Navas, T. A., D. T. Baldwin, and T. A. Stewart. 1999. RIP2 is a Raf1-activated mitogen-activated protein kinase kinase. J. Biol. Chem. 247: 33684–33690.
   Google Scholar
• Oliver, L., D. Raulais, and M. Vigny. 1992. Acidic fibroblast growth factor (aFGF) in developing normal and dystrophic (mdx) mouse muscles. Distribution in degenerating and regenerating mdx myofibres. Growth Factors 7: 97–106.
   PubMed Web of Science ®Google Scholar
• Pazdernik, N. J., D. B. Donner, M. G. Goebl, and M. A. Harrington. 1999. Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-κB. Mol. Cell. Biol. 19: 6500–6508.
   PubMedGoogle Scholar
• Rando, T. A., and H. M. Blau. 1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125: 1275–1287.
   PubMed Web of Science ®Google Scholar
• Sabourin, L. A., and M. A. Rudnicki. 2000. The molecular regulation of myogenesis. Clin. Genet. 57: 16–25.
   PubMed Web of Science ®Google Scholar
• Samuel, D. S., D. Z. Ewton, S. A. Coolican, T. D. Petley, F. J. McWade, and J. R. Florini. 1999. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts. Horm. Metab. Res. 31: 55–64.
   PubMedGoogle Scholar
• Silberstein, L., S. G. Webster, M. Travis, and H. M. Blau. 1986. Developmental progression of myosin gene expression in cultured muscle cells. Cell 46: 1075–1081.
   PubMedGoogle Scholar
• Springer, M. L., and H. M. Blau. 1997. High-efficiency retroviral infection of primary myoblasts. Somat. Cell Mol. Genet. 23: 203–209.
   PubMedGoogle Scholar
• Stanger, B. Z., P. Leder, T. H. Lee, E. Kim, and B. Seed. 1995. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 513–523.
   PubMed Web of Science ®Google Scholar
• Sun, X., J. Lee, T. Navas, D. T. Baldwin, T. A. Stewart, and V. M. Dixit. 1999. RIP3, a novel apoptosis-inducing kinase. J. Biol. Chem. 274: 16871–16875.
   PubMed Web of Science ®Google Scholar
• Thome, M., K. Hofmann, K. Burns, F. Martinon, J. L. Bodmer, C. Mattmann, and J. Tschopp. 1998. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8: 885–888.
   PubMed Web of Science ®Google Scholar
• Ting, A. T., F. X. Pimentel-Muinos, and B. Seed. 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J. 15: 6189–6196.
   PubMed Web of Science ®Google Scholar
• Tkatchenko, A. V., G. Le Cam, J. J. Léger, and C. A. Dechesne. 2000. Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim. Biophys. Acta 1500: 17–30.
   PubMedGoogle Scholar
• Winter, B., and H.-H. Arnold. 2000. Activated Raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J. Cell Sci. 113: 4211–4220.
   PubMedGoogle Scholar
• Yu, P. W., B. C. Huang, M. Shen, J. Quast, E. Chan, X. Xu, G. P. Nolan, D. G. Payan, and Y. Luo. 1999. Identification of RIP3, a RIP-like kinase that activates apoptosis and NFκB. Curr. Biol. 9: 539–542.
   PubMedGoogle Scholar
• Yun, K., and B. Wold. 1996. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8: 877–889.
   PubMed Web of Science ®Google Scholar